Scribe Therapeutics

Alameda, United States

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

$25.0M raised

Jun 2026

Grant

Biotechnology Life Science Therapeutics

Top Investors

Andreessen Horowitz RA Capital Management Menlo Ventures Wellington Management Perceptive Advisors

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Scribe Therapeutics

How much funding has Scribe Therapeutics raised?

Scribe Therapeutics has raised $25.0M in total funding. The most recent round was Grant. The last funding was announced in June 2026.

Who are Scribe Therapeutics's investors?

Scribe Therapeutics's investors include Andreessen Horowitz, RA Capital Management, Menlo Ventures, Wellington Management, Perceptive Advisors.

Where is Scribe Therapeutics headquartered?

Scribe Therapeutics is headquartered in Alameda, United States.

What does Scribe Therapeutics do?

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

What stage is Scribe Therapeutics at?

Scribe Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 18, 2026.

MLA

"Scribe Therapeutics — Funding & Investors." VCBacked, June 18, 2026, https://www.vcbacked.co/company/scribe-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2026). Scribe Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/scribe-therapeutics

Wikipedia (cite web)

{{cite web |title=Scribe Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/scribe-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 18, 2026.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K